- Malaria treatment in Africa, primarily involving antimalarial drugs such as artemisinin-based combination therapies (ACTs), is a cornerstone of public health responses due to the disease’s ongoing impact, especially among vulnerable populations such as children under five and pregnant women
- The escalating demand for effective malaria treatments is fueled by strong government initiatives, international funding, growing awareness, and the urgent need to address emerging drug-resistant strains of malaria
- Nigeria dominated the malaria treatment market in Africa with the largest revenue share of 27.8% in 2024, attributed to its high malaria burden, expansive population, and robust national malaria control strategies supported by global health agencies such as WHO and the Global Fund
- Uganda is expected to be the fastest-growing country in the malaria treatment market during the forecast period due to rising public health investments, improvements in diagnostic coverage, and expanding access to ACTs through both public and private channels
- Medication, segment dominated the Africa malaria treatment market with a market share of 91.7% in 2024, driven by its widespread use in first-line treatment protocols, affordability, and large-scale distribution through government and donor-supported health programs
